Status:
UNKNOWN
Monitoring Concentration and Pharmacodynamic Effects of Tacrolimus in Peripheral Blood Lymphocytes of Kidney Transplant Recipients
Lead Sponsor:
University of Sao Paulo General Hospital
Collaborating Sponsors:
Maria da Luz Fernandes
Paschoalina Romano
Conditions:
Kidney Transplantation
Rejection
Eligibility:
All Genders
18-60 years
Brief Summary
Therapeutic drug monitoring (TDM) of immunosuppressive drugs is used to improve the immunosuppressive effect while minimizing the toxicity related to exposition to high serum levels. Although TDM is w...
Eligibility Criteria
Inclusion
- Kidney transplant recipients with a well functioning graft (serum creatinine ≤ 2,0 mg/dL at inclusion)
- Must be on tacrolimus therapy
- Must be on short term follow up time (1 to 5 months) after surgery
Exclusion
- A concomitant second solid organ transplant
- Immunosuppression not containing tacrolimus
Key Trial Info
Start Date :
March 8 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2018
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT03425071
Start Date
March 8 2016
End Date
December 1 2018
Last Update
February 7 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital das Clínicas - University of Sao Paulo
São Paulo, São Paulo, Brazil, 05403900